Vantage Investment Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
Vantage Investment Advisors's MRK Position: Q3 2018 in Review
Vantage Investment Advisors increased its Merck (MRK) stake by 6.5% in Q3 2018, buying an estimated $37.7K and bringing the position to 9,669 shares worth $618K. The position accounts for 0.13% of the portfolio, ranked #85.
Vantage Investment Advisors first reported a position in MRK in Q4 2013 and has held it in 20 quarters since. The position peaked at $6.06M in Q3 2017. 2,056 funds tracked by Wall St. Rank hold MRK as of Q3 2018.
- Vantage Investment Advisors held 9,669 shares of Merck worth $618K as of Q3 2018.
- Vantage Investment Advisors bought 591 Merck shares in Q3 2018, an estimated $37.7K.
- Merck made up 0.13% of Vantage Investment Advisors's portfolio in Q3 2018, its #85 holding.
- Vantage Investment Advisors first reported a position in Merck in Q4 2013 and has held it in 20 quarters since.
- Vantage Investment Advisors's Merck position peaked at $6.06M in Q3 2017.
- 2,056 funds tracked by Wall St. Rank held Merck as of Q3 2018.
Based on Vantage Investment Advisors's 13F filing for Q3 2018, filed 9 Nov 2018.